Design, Synthesis, Antimicrobial Activity, and Molecular Docking of Some New Diclofenac Derivatives

References

• Devleena Tiglani, Avijit Mazumder, Mohammad Shahar Yar, Rajnish Kumar, and Mohamed Jawed Ahsan, “Benzimidazole-Quinoline Hybrid Scaffold as Promising Pharmacological Agents: A Review Benzimidazole-Quinoline Hybrid Scaffold as Promising Pharmacological Agents: A Review,” Polycyclic Aromatic Compounds (2021): 1–23. doi:10.1080/10406638.2021.1942933.
   Web of Science ®Google Scholar
• V.K. Tammara, M.M. Narurkar, A.M. Crider, and M.A. Khan, “Morpholinoalkyl Ester Prodrugs of Diclofenac: Synthesis, In Vitro and In Vivo Evaluation,” Journal of Pharmaceutical Sciences 83, no. 5 (1994): 644–8. doi:10.1002/jps.2600830510.
   PubMed Web of Science ®Google Scholar
• C.J. Smith, Y. Zhang, C.M. Koboldt, J. Muhammad, B.S. Zweifel, A. Shaffer, J.J. Talley, J.L. Masferrer, K. Seibert, and P.C. Isakson, “Pharmacological Analysis of Cyclooxygenase-1 in Inflammation,” Proceedings of the National Academy of Sciences of the United States of America 95, no. 22 (1998): 13313–8. doi:10.1073/pnas.95.22.13313.
   PubMed Web of Science ®Google Scholar
• T.D. Warner, F. Giuliano, I. Vojnovic, A. Bukasa, J.A. Mitchell, and J.R. Vane, “Nonsteroid Drug Selectivities for Cyclo-Oxygenase-1 Rather than Cyclo-Oxygenase-2 Are Associated with Human Gastrointestinal Toxicity: A Full in Vitro Analysis,” Proceedings of the National Academy of Sciences of the United States of America 96, no. 13 (1999): 7563–8. doi:10.1073/pnas.96.13.7563.
   PubMed Web of Science ®Google Scholar
• Y.A. Ammar, M.M. Khalifa, S.I. Eisa, and M.M.F. Ismail, “New Naproxen Analogs: Synthesis, Docking and anti-Inflammatory Evaluation,” Polycyclic Aromatic Compounds (2021): 1–20. doi:10.1080/10406638.2020.1871037.
   Google Scholar
• N.A. Peerzade, S.Y. Jadhav, B.D. Varpe, A.A. Kulkarni, and R.B. Bhosale, “Green Synthesis, Molecular Docking, in Silico ADME and Biological Evaluation of Methoxy Substituted 1,5-Benzodiazepines as Potential Antioxidant, anti-Inflammatory, and Antidiabetic Agents,” Polycyclic Aromatic Compounds (2021): 1–14. doi:10.1080/10406638.2021.1878244.
   Web of Science ®Google Scholar
• L.J. Marnett, and A.S. Kalgutkar, “Cyclooxygenase 2 Inhibitors: Discovery, Selectivity and the Future,” Trends in Pharmacological Sciences. 20, no. 11 (1999): 465–9. doi:10.1016/S0165-6147(99)01385-1.
   PubMed Web of Science ®Google Scholar
• G. Dannhardt, and W. Kiefer, “Cyclooxygenase Inhibitors – Current Status and Future Prospects,” European Journal of Medicinal Chemistry 36, no. 2 (2001): 109–26. doi:10.1016/S0223-5234(01)01197-7.
   PubMed Web of Science ®Google Scholar
• L.J. Marnett, and A.S. Kalgutkar, “Design of Selective Inhibitors of Cyclooxygenase-2 as Nonulcerogenic anti-Inflammatory Agents,” Current Opinion in Chemical Biology 2, no. 4 (1998): 482–90. doi:10.1016/S1367-5931(98)80124-5.
   PubMed Web of Science ®Google Scholar
• D.C. Young, “Pharmacophore Models,” Computer-Aided Drug Design (2009): 161–9. doi: 10.1002/9780470451854.ch13
   Google Scholar
• J.J. Talley, D.L. Brown, J.S. Carter, M.J. Graneto, C.M. Koboldt, J.L. Masferrer, W.E. Perkins, R.S. Rogers, A.F. Shaffer, Y.Y. Zhang, et al., “4-[5-Methyl-3-Phenylisoxazol-4-yl]-Benzenesulfonamide, Valdecoxib: A Potent and Selective Inhibitor of COX-2,” Journal of Medicinal Chemistry 43, no. 5 (2000): 775–7. doi:10.1021/jm990577v.
   PubMed Web of Science ®Google Scholar
• A.S. Michaelidou, and D. Hadjipavlou-Litina, “Nonsteroidal anti-Inflammatory Drugs (NSAIDs): A Comparative QSAR Study,” Chemical Reviews 105, no. 9 (2005): 3235–71. doi:10.1021/cr040708m.
   PubMed Web of Science ®Google Scholar
• L.J. Crofford, “Use of NSAIDs in Treating Patients with Arthritis,” Arthritis Research and Therapy 15, no. 3 (2013): S2.
   PubMedGoogle Scholar
• D. Picot, P.J. Loll, and R.M. Garavito, “The X-Ray Crystal Structure of the Membrane Protein Prostaglandin H 2 Synthase-1,” Nature 367, no. 6460 (1994): 243–9. doi:10.1038/367243a0.
   PubMed Web of Science ®Google Scholar
• T.D. Penning, J.J. Talley, S.R. Bertenshaw, J.S. Carter, P.W. Collins, S. Docter, M.J. Graneto, L.F. Lee, J.W. Malecha, J.M. Miyashiro, et al., “Synthesis and Biological Evaluation of the 1, 5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3-(Trifluoromethyl)-1 H-Pyrazol-1-yl] Benzenesulfonamide (SC-58635, Celecoxib),” Journal of Medicinal Chemistry. 2623, no. 96 (1997): 1347–65.
   Google Scholar
• A.S. Grewal, “Isatin Derivatives with Several Biological Activities,” International Journal of Pharmaceutical Research 6, no. 1 (2014): 1–7.
   Google Scholar
• D. Sriram, P. Yogeeswari, and R.V. Devakaram, “Synthesis, In Vitro and In Vivo Antimycobacterial Activities of Diclofenac Acid Hydrazones and Amides,” Bioorganic & Medicinal Chemistry 14, no. 9 (2006): 3113–8. doi:10.1016/j.bmc.2005.12.042.
   PubMed Web of Science ®Google Scholar
• A. Kocabalkanlı, G. Cihan-Üstündağ, L. Naesens, E. Mataracı-Kara, M. Nassozi, and G. Çapan, “Diclofenac-Based Hydrazones and Spirothiazolidinones: Synthesis, Characterization, and Antimicrobial Properties,” Archiv der Pharmazie 350, no. 5 (2017): 1–11.
   Web of Science ®Google Scholar
• M. Barbarić, M. Kralj, M. Marjanović, I. Husnjak, K. Pavelić, J. Filipović-Grcić, D. Zorc, and B. Zorc, “Synthesis and In Vitro Antitumor Effect of Diclofenac and Fenoprofen Thiolated and Nonthiolated Polyaspartamide-Drug Conjugates,” European Journal of Medicinal Chemistry 42, no. 1 (2007): 20–9. doi:10.1016/j.ejmech.2006.08.009.
   PubMed Web of Science ®Google Scholar
• Jack Cuzick, Florian Otto, John A. Baron, Powel H. Brown, John Burn, Peter Greenwald, Janusz Jankowski, Carlo La Vecchia, Frank Meyskens, Hans Jörg Senn, et al., “Aspirin and Non-Steroidal anti-Inflammatory Drugs for Cancer Prevention: An International Consensus Statement,” The Lancet. Oncology 10, no. 5 (2009): 501–7. doi:10.1016/S1470-2045(09)70035-X.
   PubMed Web of Science ®Google Scholar
• Terry W. Moody, Christopher Switzer, Wilmarie Santana-Flores, Lisa A. Ridnour, Marc Berna, Michelle Thill, Robert T. Jensen, Anna Sparatore, Piero Del Soldato, Grace C. Yeh, et al., “Dithiolethione Modified Valproate and Diclofenac Increase E-Cadherin Expression and Decrease Proliferation of Non-Small Cell Lung Cancer Cells,” Lung Cancer 68, no. 2 (2010): 154–60. doi:10.1016/j.lungcan.2009.06.012.
   PubMed Web of Science ®Google Scholar
• A. Galisteo, F. Jannus, A. García-García, H. Aheget, S. Rojas, J.A. Lupiañez, A. Rodríguez-Diéguez, F.J. Reyes-Zurita, and J.F. Quílez Del Moral, “Diclofenac n-Derivatives as Therapeutic Agents with anti-Inflammatory and anti-Cancer Effect,” International Journal of Molecular Sciences 22, no. 10 (2021): 5067.
   PubMed Web of Science ®Google Scholar
• J. Kaur, T. Chikate, P. Bandyopadhyay, S. Basu, and R. Chikate, “Cu(II) Complexes of Hydrazones–NSAID Conjugates: synthesis, Characterization and Anticancer Activity,” Journal of Coordination Chemistry 73, no. 23 (2020): 3186–202. doi:10.1080/00958972.2020.1843160.
   Web of Science ®Google Scholar
• S.A. Hasan, and A.N. Elias, “Synthesis of New Diclofenac Derivatives by Coupling with Chalcone Derivatives as Possible Mutual Prodrugs,” International Journal of Pharmacy and Pharmaceutical Sciences 6, no. 1 (2014): 239–45.
   Google Scholar
• Y. Shepeta, A. Lozynskyi, M. Sulyma, I. Nektegayev, P. Grellier, and R. Lesyk, “Synthesis and Biological Activity Evaluation of New Thiazolidinone-Diclofenac Hybrid Molecules,” Phosphorus, Sulfur, and Silicon and the Related Elements 195, no. 10 (2020): 836–41. doi:10.1080/10426507.2020.1759060.
   Web of Science ®Google Scholar
• Mahesh B. Palkar, Anuj S. Singhai, Pradeepkumar M. Ronad, A.H.M. Vishwanathswamy, Thippeswamy S. Boreddy, Veeresh P. Veerapur, Mahamadhanif S. Shaikh, Rajesh A. Rane, and Rajshekhar Karpoormath, “Synthesis, Pharmacological Screening and in Silico Studies of New Class of Diclofenac Analogues as a Promising anti-Inflammatory Agents,” Bioorganic & Medicinal Chemistry 22, no. 10 (2014): 2855–66. doi:10.1016/j.bmc.2014.03.043.
   PubMed Web of Science ®Google Scholar
• Shazia Shah, Nida Siraj Kazmi, Almas Jabeen, Aisha Faheem, Nida Dastagir, Tariq Ahmed, Khalid Mohammed Khan, Shakil Ahmed, Abeer Raza, Shahnaz Perveen, et al., “Diclofenac 1,3,4-Oxadiazole Derivatives; Biology-Oriented Drug Synthesis (BIODS) in Search of Better Non-Steroidal, Non-Acid Antiinflammatory Agents,” Medicinal Chemistry 14, no. 7 (2018): 674–87. doi:10.2174/1573406414666180321141555.
   PubMed Web of Science ®Google Scholar
• F. Hafeez, A.F. Zahoor, S. Ahmad, M. Ahmad, and S. Faiz, “Recent Progress in the Synthesis of Diclofenac Based NSAIDs Analogs/Derivatives,” Synthetic Communications 49, no. 3 (2019): 325–50. doi:10.1080/00397911.2018.1515367.
   Web of Science ®Google Scholar
• I.M.M. Paino, V.F. Ximenes, L.M. da Fonseca, M.P.P. Kanegae, N.M. Khalil, and I.L. Brunetti, “Effect of Therapeutic Plasma Concentrations of Non-Steroidal anti-Inflammatory Drugs on the Production of Reactive Oxygen Species by Activated Rat Neutrophils,” Brazilian Journal of Medical and Biological Research 38, no. 4 (2005): 543–51. doi:10.1590/s0100-879x2005000400007.
   PubMed Web of Science ®Google Scholar
• P.V. Kumar, K.M. Reddy, and V.R. Rao, “Synthesis of Some 7-Methyl-3-(2-Oxo-2H-Chromen-3-yl)-5H[1,3]Thiazolo[3,2-a]-Pyrimidin-5-Ones,” Indian Journal of Chemistry – Section B Organic and Medicinal Chemistry 47, no. 5 (2008): 759–63.
   Web of Science ®Google Scholar
• M.H. Mahmoud, A.M.K. El-Dean, S.A. Abdel-Mohsen, and M.S. Tolba, “New Diclofenac Derivatives as anti-Microbial, anti-Inflammatory Agents: Design, Synthesis, Biological Screening, and Molecular Docking Study,” Russian Journal of Bioorganic Chemistry 47, no. 1 (2021): 208–20. doi:10.1134/S1068162021010088.
   Web of Science ®Google Scholar
• M. Ahmed, M. Sayed, A.F. Saber, R. Hassanien, A.M. Kamal El-Dean, and M.S. Tolba, “Synthesis, Characterization, and Antimicrobial Activity of New Thienopyrimidine Derivatives,” Polycyclic Aromatic Compounds (2020): 1–10. doi:10.1080/10406638.2020.1852587.
   Web of Science ®Google Scholar
• A.F. Saber, M. Sayed, M.S. Tolba, A.M. Kamal El-Dean, R. Hassanien, and M. Ahmed, “A Facile Method for Preparation and Evaluation of the Antimicrobial Efficiency of Various Heterocycles Containing Thieno,” Synthetic Communications 51, no. 3 (2021): 398–409. doi:10.1080/00397911.2020.1829645.
   Web of Science ®Google Scholar
• M. Sayed, A.M. Kamal El-Dean, M. Ahmed, and R. Hassanien, “Synthesis of Some Heterocyclic Compounds Derived from Indole as Antimicrobial Agents,” Synthetic Communications 48, no. 4 (2018): 413–21. doi:10.1080/00397911.2017.1403627.
   Web of Science ®Google Scholar
• S.A.A. Abdel-Raheem, A.M. Kamal El-Dean, R. Hassanien, M.E.A. El-Sayed, M. Sayed, and A.A. Abd-Ella, “Synthesis and Spectral Characterization of Selective Pyridine Compounds as Bioactive Agents,” Current Chemistry Letters 10, no. 3 (2021): 255–60. doi:10.5267/j.ccl.2021.2.001.
   Google Scholar
• M. Sayed, A.M. Kamal El-Dean, M. Ahmed, and R. Hassanien, “Design, Synthesis, and Characterization of Novel Pyrimidines Bearing Indole as Antimicrobial Agents,” Journal of the Chinese Chemical Society 66, no. 2 (2019): 218–25. doi:10.1002/jccs.201800115.
   Web of Science ®Google Scholar
• M. Sayed, A.M. Kamal El-Dean, M. Ahmed, and R. Hassanien, “Synthesis, Characterization, and Screening for anti-Inflammatory and Antimicrobial Activity of Novel Indolyl Chalcone Derivatives,” Journal of Heterocyclic Chemistry 55, no. 5 (2018): 1166–75. doi:10.1002/jhet.3149.
   Web of Science ®Google Scholar
• Osama Younis, Esam A. Orabi, Adel M. Kamal, Mostafa Sayed, Reda Hassanien, Rebecca L. Davis, Osamu Tsutsumi, and Mostafa Ahmed, “Aggregation-Induced Emission with White, Green, or Blue Luminescence from Biologically-Active Indole Derivatives,” Optical Materials 100, no. 1 (2020): 109713–23. nodoi:10.1016/j.optmat.2020.109713.
   Google Scholar
• Mostafa Sayed, Osama Younis, Reda Hassanien, Mostafa Ahmed, Ahmed A.K. Mohammed, Adel M. Kamal, and Osamu Tsutsumi, “Design and Synthesis of Novel Indole Derivatives with Aggregation-Induced Emission and Antimicrobial Activity,” Journal of Photochemistry and Photobiology A: Chemistry 383, no. 7 (2019): 111969–79. doi:10.1016/j.jphotochem.2019.111969.
   Google Scholar
• M.S. Tolba, A.M. Kamal El-Dean, M. Ahmed, and R. Hassanien, “Synthesis, Reactions, and Biological Study of Some New Thienopyrimidine Derivatives as Antimicrobial and anti-Inflammatory Agents,” Journal of the Chinese Chemical Society 66, no. 5 (2019): 548–57. doi:10.1002/jccs.201800292.
   Web of Science ®Google Scholar
• Mostafa Ahmed, Osama Younis, Esam A. Orabi, Ahmed M. Sayed, Adel M. Kamal El-Dean, Reda Hassanien, Rebecca L. Davis, Osamu Tsutsumi, and Mahmoud S. Tolba, “Synthesis of Novel Biocompatible Thienopyrimidine Chromophores with Aggregation-Induced Emission Sensitive to Molecular Aggregation,” ACS Omega 5, no. 46 (2020): 29988–30000. doi:10.1021/acsomega.0c04358.
   PubMed Web of Science ®Google Scholar
• M.S. Tolba, A.F. Al-Hossainy, A.M. Kamal Eldean, and O. Younis, “From Blue to Green Photoluminescence: Design, Synthesis, and DFT Calculations of Heterocyclic Compounds Containing Chromenothienopyrimidine Moiety,” Asian Journal of Organic Chemistry 5, no. 5 (2022): 202100801– 12.
   Google Scholar
• Ahmed I.A. Soliman, Mostafa Sayed, Mahmoud M. Elshanawany, Osama Younis, Mostafa Ahmed, Adel M. Kamal El-Dean, Aboel-Magd A. Abdel-Wahab, Josef Wachtveitl, Markus Braun, Pedram Fatehi, et al., “Base-Free Synthesis and Photophysical Properties of New Schiff Bases Containing Indole Moiety,” ACS Omega 7, no. 12 (2022): 10178–86. nodoi:10.1021/acsomega.1c06636.
   PubMed Web of Science ®Google Scholar
• Osama Younis, Mostafa Sayed, Ahmed A.K. Mohammed, Mahmoud S. Tolba, Reda Hassanien, Adel M. Kamal El-Dean, Osamu Tsutsumi, and Mostafa Ahmed, “Solid-State Luminescent Materials Containing Both Indole and Pyrimidine Moieties: Design, Synthesis, and Density Functional Theory Calculations,” ACS Omega 7, no. 17 (2022): 15016–26. nodoi:10.1021/acsomega.2c00775.
   PubMed Web of Science ®Google Scholar
• O. Younis, A.F. Al-Hossainy, M. Sayed, A.M. Kamal El-Dean, and M.S. Tolba, “Synthesis and Intriguing Single-Component White-Light Emission from Oxadiazole or Thiadiazole Integrated with Coumarin Luminescent Core,” Journal of Photochemistry and Photobiology A: Chemistry 431 (2022): 113992. doi:10.1016/j.jphotochem.2022.113992.
   Web of Science ®Google Scholar
• V.V. Syakaev, S.N. Podyachev, B.I. Buzykin, S.K. Latypov, W.D. Habicher, and A.I. Konovalov, “NMR Study of Conformation and Isomerization of Aryl- and Heteroarylaldehyde 4-Tert-Butylphenoxyacetylhydrazones,” Journal of Molecular Structure 788, no. 1–3 (2006): 55–62. doi:10.1016/j.molstruc.2005.11.018.
   Web of Science ®Google Scholar
• Ravindra P. Jumde, Melissa Guardigni, Robin M. Gierse, Alaa Alhayek, Di Zhu, Zhoor Hamid, Sandra Johannsen, Walid A.M. Elgaher, Philipp J. Neusens, Christian Nehls, et al., “Hit-Optimization Using Target-Directed Dynamic Combinatorial Chemistry: Development of Inhibitors of the anti-Infective Target 1-Deoxy-d-Xylulose-5-Phosphate Synthase,” Chemical Science 12, no. 22 (2021): 7775–85. doi:10.1039/d1sc00330e.
   PubMed Web of Science ®Google Scholar
• S.G. Dastidar, K. Ganguly, K. Chaudhuri, and A.N. Chakrabarty, “The anti-Bacterial Action of Diclofenac Shown by Inhibition of DNA Synthesis,” International Journal of Antimicrobial Agents 14, no. 3 (2000): 249–51. doi:10.1016/S0924-8579(99)00159-4.
   PubMed Web of Science ®Google Scholar
• Noton Kumar Dutta, Subramanian Annadurai, Kaushiki Mazumdar, Sujata G. Dastidar, Jette E. Kristiansen, Joseph Molnar, Marta Martins, and Leonard Amaral, “Potential Management of Resistant Microbial Infections with a Novel Non-Antibiotic: The anti-Inflammatory Drug Diclofenac Sodium,” International Journal of Antimicrobial Agents 30, no. 3 (2007): 242–9. doi:10.1016/j.ijantimicag.2007.04.018.
   PubMed Web of Science ®Google Scholar
• Zhou Yin, Yao Wang, Louise R. Whittell, Slobodan Jergic, Michael Liu, Elizabeth Harry, Nicholas E. Dixon, Michael J. Kelso, Jennifer L. Beck, Aaron J. Oakley, et al., “DNA Replication is the Target for the Antibacterial Effects of Nonsteroidal anti-Inflammatory Drugs,” Chemistry & Biology 21, no. 4 (2014): 481–7. doi:10.1016/j.chembiol.2014.02.009.
   PubMedGoogle Scholar
• M.C. Noverr, S.M. Phare, G.B. Toews, M.J. Coffey, and G.B. Huffnagle, “Albicans Produce Immunomodulatory Prostaglandins,” Infection and Immunity 69, no. 5 (2001): 2957–63. doi:10.1128/IAI.69.5.2957-2963.2001.
   PubMed Web of Science ®Google Scholar
• D.I. Tsitsigiannis, J.W. Bok, D. Andes, K.F. Nielsen, J.C. Frisvad, and N.P. Keller, “Aspergillus Cyclooxygenase-like Enzymes Are Associated with Prostaglandin Production and Virulence,” Infection and Immunity 73, no. 8 (2005): 4548–59. doi:10.1128/IAI.73.8.4548-4559.2005.
   PubMed Web of Science ®Google Scholar
• Scott W. Rowlinson, James R. Kiefer, Jeffery J. Prusakiewicz, Jennifer L. Pawlitz, Kevin R. Kozak, Amit S. Kalgutkar, William C. Stallings, Ravi G. Kurumbail, and Lawrence J. Marnett, “A Novel Mechanism of Cyclooxygenase-2 Inhibition Involving Interactions with Ser-530 and Tyr-385,” The Journal of Biological Chemistry 278, no. 46 (2003): 45763–4576. (003) doi:10.1074/jbc.M305481200.
   PubMed Web of Science ®Google Scholar
• B. Campbell, “Technical Section,” The Annals of the Royal College of Surgeons of England 95, no. 7 (2013): 532. doi:10.1308/rcsann.2013.95.7.532.
   PubMedGoogle Scholar
• Walid A.M. Elgaher, Kamal K. Sharma, Jörg Haupenthal, Francesco Saladini, Manuel Pires, Eleonore Real, Yves Mély, and Rolf W. Hartmann, “Discovery and Structure-Based Optimization of 2-Ureidothiophene-3-Carboxylic Acids as Dual Bacterial RNA Polymerase and Viral Reverse Transcriptase Inhibitors,” Journal of Medicinal Chemistry 59, no. 15 (2016): 7212–7222. doi:10.1021/acs.jmedchem.6b00730.
   PubMed Web of Science ®Google Scholar